Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
Sets price band at ?695 to ?735 per Equity Share
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Oteseconazole Capsules were found to be safe and more effective than fluconazole
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Subscribe To Our Newsletter & Stay Updated
